4121 The beneficial, anti-fibrotic effects of chemokine receptor 2 and 5 antagonists on fat-exposed mouse primary hepatic stellate cells (pHSCs)

OBJECTIVES/GOALS: Non-alcoholic steatohepatitis (NASH) is a leading cause of cirrhosis in the world for which no anti-fibrotic therapies exist. We hypothesized that BMS-22 and maraviroc (MVC), chemokine receptor 2 (CCR2) and 5 (CCR5) antagonists, respectively, would diminish the fibrogenic activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruger, Annie J., Bergman, Kruger, Gay, Martha, Cao, Hong, Tucker, Robin, Shivapurkar, Narayan, Smith, Jill P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Mechanistic Basic to Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823193/
http://dx.doi.org/10.1017/cts.2020.317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823193/
http://dx.doi.org/10.1017/cts.2020.317

Ejemplares similares